Ovarian cancer is one of the most deadly cancers affecting women, it causes 140,000 deaths each year, and 1 in 75 women worldwide will be diagnosed with it in their lifetime. Only 45% of women diagnosed with ovarian cancer have a chance of surviving for 5 years. This is the lowest survival rate of all gynaecological cancers and quite a lot lower than that seen in women with breast cancer.

For these reasons, doctors and researchers at Hospital del Mar are working on a research project to improve the detection of the disease, personalise treatment and increase survival.

The aim of the research project is to implement the use of liquid biopsies to obtain very precise information about the evolution of the disease in each patient and allow doctors to select the best treatment and adapt this for the women affected.